- TL 1997 4-11
Treatment Action Group (TAG): Volume 4, Issue 11 -December 1997 Worldwide Epidemic Just When You Thought the Global HIV/AIDS Picture Couldn't Get Any Worse --It Did -What could a vaccine do? As people in the North America, Western Europe and Australia begin to live longer with HIV and AIDS (and even begin to savor the
- TL 1997 4-10
Treatment Action Group (TAG): Volume 4, Issue 10 -November 1997 Thumbs Up,Thumbs Down The FDA's Oncologic Drug Advisory Committee Decides the Fate of Two Drugs for AIDS-Related Malignancies Nowhere near bowled over On June 23rd, the FDA's Oncologic Drug Advisory Committee held a hearing to determine the fate of Bristol
- TL 1997 4-9
Treatment Action Group (TAG): Volume 4, Issue 9 -October 1997 Skullduggery Over FDA Republicans and Pharmaceutical Industry Target the FDA in a Dangerous Plan to Undermine the FDA Two lone voices Gregg Gonsalves, TAG's Policy Director and Washington watchdog, has just returned from a week in our nation's capitol, on th
- TL 1997 4-8
Treatment Action Group (TAG): Volume 4, Issue 8 -September 1997 In the Eye of the Storm Having Temporarily Suspended Disbelief, Would-Be Eradicatee Looks Forward to Still Uncertain Future A perilous seduction Irrational exuberance might not be the sole domain of streets Broad and Wall. Speculation in AIDS futures has a
- TL 1997 4-7
Treatment Action Group (TAG): Volume 4, Issue 7 -August 1997 Scammed Roche Racks Up Millions In Early Saquinavir Sales While Unwitting Patients Prime Themselves for Protease X-Resistance Community cries for compensation Cynical, greedy, manipulative, opportunistic, penny-pinching, short-sighted, slipshod. Do these word
- TL 1997 4-6
Treatment Action Group (TAG): Volume 4, Issue 6 -June/July 1997 Panel Embraces Maximum Viral Suppression as Goal of Therapy Drug Company Bonanza Creates Headaches for Third-Party Payers and AIDS Treatment Educators Eleventh hour backstage skullduggery stymied by unified community "And What Rough Beast, Its Hour Come Ro
- TL 1997 4-5
Treatment Action Group (TAG): Volume 4 Issue 5 May, 1997 Under the Knife HIV-Infected Kids Choke in the Dust of Adult Advances While Their Advocates Struggle to Maintain Funding 'Two to three year lag' As the AIDS epidemic nears the end of its second decade, pediatric AIDS research has become a flashpooin for concerns
- TL 1997 4-4
Treatment Action Group (TAG): Volume 4 Issue 4 April 1997 Eluding Public Scrutiny, Nelfinavir Becomes the Fourth Protease Inhibitor to Hit the Pharmacy Shelves Resistance enigma The US Food & Drug Administration (FDA), which will soon be under the control of Acting Commissioner Dr. Michael Friedman when Commissioner Dr
- TL 1997 4-3
Treatment Action Group (TAG): Volume 4 Issue 3 March 1997 START Stopped Nearly Everyone Agrees On the Need for 'Strategy' Type Clinical Studies --And That's Where Consensus Ends An intrepid Dr. Lange scales Mt. Sinai First there was the CPCRA's "Moving Target" protocol, which entailed half a decade of arduous, dogchass
- TL 1997 4-2
Treatment Action Group (TAG): Volume 4 Issue 2 February 1997 Druthers, Grim Activist Epistler Chronicles Frightening Tales of Multiply Resistant HIV from D.C. Principles Panel Toxic cocktail The NIH panel convened late last November to develop new state-of-the-art guidelines for the treatment of HIV infection included
- TL 1997 4-1
Treatment Action Group (TAG): Volume 4 Issue 1 -January 1997 Four in Favor, Four Against Long-Awaited Non-Nuke Receives Mixed Reviews at Agency Hearing Clinical benefit elusive In a November 22nd FDA hearing that harkened back to the bad old days of ddC, the Food and Drug Administration's Antiviral Drugs Advisory Commi